The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of MAGNA PURE 96 INSTRUMENTS. The contract, which has a potential value of $180,000.00, does not have a set-aside designation and has an anticipated completion date of April 15, 2022. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $143,672.81 contract is for ROCHE REAGENTS AND SUPPLIES with a completion date of December 31, 2018. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide LAB SUPPLIES LINEAR ARRAY KITS. The contract, valued at $148,800.00, is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type. The place of performance is Atlanta, Georgia. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in...
The Department of the Air Force Materiel Command awarded a firm-fixed-price delivery order contract to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide CT/NG AMPLIFICATION/DETECTION KIT V2 with a completion date of September 4, 2018 and a potential value of $422,938.20. Roche Diagnostics, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment, has received numerous federal contract awards to supply critical care...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The $105,921.20 contract is for sample reagents with a completion date of November 7, 2022. This award was not set aside for any socioeconomic category. Roche Diagnostics has held numerous federal contracts, including...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for $209,098.00 worth of laboratory supplies. This was a firm fixed price contract with no set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract was awarded...
This is a $84,382.00 firm fixed price purchase order awarded by the Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of Roche Magna Pure Kits/Zika and does not have a set-aside designation. Roche Diagnostics has been awarded numerous federal contracts and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer, for the supply of lab supplies. The potential value of the contract is $119,383.20, and the period of performance runs through April 1, 2019. The contract does not have a set-aside designation. Roche Diagnostics is a provider of in vitro diagnostics, reagents, laboratory instruments, and...
This $90,000.00 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for MAGNA PURE 96 products. The contract has no set-aside designation and has a completion date of July 23, 2022. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. They have previously received prime contract and subcontract awards from various federal...
This is a delivery order awarded by the Department of Health and Human Services National Institutes of Health Clinical Center to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of reagents, kits, and consumables for Roche Cobas Ampliprep and Taqman instruments. The contract, which does not have a set-aside designation, is a Firm Fixed Price agreement with a potential value of $221,284.57. Roche Diagnostics is a foreign-owned, for-profit manufacturer...